Difference between revisions of "Ultrasound-guided hip joint injection"

From radlines.org
Jump to navigation Jump to search
(Expanded)
(→‎Report: + Information)
 
(10 intermediate revisions by the same user not shown)
Line 1: Line 1:
−
[[File:Hip prosthesis components.jpg|thumb|160px|Main components of a hip prosthesis<ref>{{cite web|url=http://illumin.usc.edu/61/total-hip-replacement/|title=Total Hip Replacement|website=University of Southern California|author=Andrew Still|date=2002-11-02|accessdate=2017-01-05}}</ref>]]
 
 
{{Top
 
{{Top
 
|author1=[[User:Mikael Häggström|Mikael Häggström]]
 
|author1=[[User:Mikael Häggström|Mikael Häggström]]
Line 22: Line 21:
 
:*30mg mepivacaine (such as 3 ml of 1% Carbocaine)
 
:*30mg mepivacaine (such as 3 ml of 1% Carbocaine)
 
:*25mg bupivacaine (such as 5ml of Marcaine 0.5%)<ref name="AndersonHerring2013">{{cite journal|last1=Anderson|first1=Erik|last2=Herring|first2=Andrew|last3=Bailey|first3=Caitlin|last4=Mantuani|first4=Daniel|last5=Nagdev|first5=Arun|title=Ultrasound-guided Intraarticular Hip Injection for Osteoarthritis Pain in the Emergency Department|journal=Western Journal of Emergency Medicine|volume=14|issue=5|year=2013|pages=505–508|issn=1936900X|doi=10.5811/westjem.2013.2.13966}}</ref>
 
:*25mg bupivacaine (such as 5ml of Marcaine 0.5%)<ref name="AndersonHerring2013">{{cite journal|last1=Anderson|first1=Erik|last2=Herring|first2=Andrew|last3=Bailey|first3=Caitlin|last4=Mantuani|first4=Daniel|last5=Nagdev|first5=Arun|title=Ultrasound-guided Intraarticular Hip Injection for Osteoarthritis Pain in the Emergency Department|journal=Western Journal of Emergency Medicine|volume=14|issue=5|year=2013|pages=505–508|issn=1936900X|doi=10.5811/westjem.2013.2.13966}}</ref>
−
*Cortisone, for example:
+
*Glucocorticoid, for example:
 
:*40mg triamcinolone (such as 1ml of 40 mg/ml)<ref name="AndersonHerring2013"/>
 
:*40mg triamcinolone (such as 1ml of 40 mg/ml)<ref name="AndersonHerring2013"/>
 +
 +
===Patient information===
 +
In osteoarthritis patients, at least when not having had repeated injections, inform that the local anesthetic effect will wear off after about 4 to 6 hours, and it will take 2 to 7 days before the glucocorticoid will take effect, so that there may be increased pain in the meantime.<ref name=MedlinePlus>{{cite web|url=https://medlineplus.gov/ency/article/007633.htm|title=Hip joint injection|author=Benjamin Ma|accessdate=2019-03-22|website=MedlinePlus (United States National Library of Medicine)}} Review Date 11/27/2016</ref>
  
 
==Procedure==
 
==Procedure==
−
*Perform a '''preliminary sonography''', including color Doppler of the area to be punctured, to define the relationship of adjacent neurovascular structures.<ref name="YeapRobinson2017"/>
+
*Perform a '''preliminary sonography''', including color Doppler of the area to be punctured, to define the relationship of adjacent neurovascular structures.<ref name="YeapRobinson2017"/> Preferably, also evaluate the joint area for any joint effusion, or any thickening or hyperemia of the joint capsule.
 
*Decide which '''approach''' to use. Two common anterior approaches are typically used both with the patient lying supine:
 
*Decide which '''approach''' to use. Two common anterior approaches are typically used both with the patient lying supine:
−
[[File:Hip joint injection by anterior longitudinal approach.jpg|thumb|left|Anterior longitudinal approach. An arrow parallel to the long axis of the transducer is drawn on the skin adjacent to the end of transducer where the needle will be introduced.<ref name="YeapRobinson2017"/>]]
+
[[File:Hip joint injection by anterior longitudinal approach.jpg|thumb|200px|Anterior longitudinal approach. An arrow parallel to the long axis of the transducer is drawn on the skin adjacent to the end of transducer where the needle will be introduced.<ref name="YeapRobinson2017"/>]]
−
[[File:Ultrasonography of hip joint injection by anterior longitudinal approach.jpg|thumb|Anterior longitudinal approach. The needle is introduced from an inferior and anterior approach, lateral to the femoral neurovascular bundle (arrow). A, acetabulum; H, femoral head; N, femoral neck; double arrow – anterior joint recess.<ref name="YeapRobinson2017"/>]]
 
 
:*The '''anterior longitudinal''' approach: the probe is aligned along the long axis of the femoral neck. The needle is introduced from an anteroinferior approach and is passed into the anterior joint recess at the femoral head-neck junction.  
 
:*The '''anterior longitudinal''' approach: the probe is aligned along the long axis of the femoral neck. The needle is introduced from an anteroinferior approach and is passed into the anterior joint recess at the femoral head-neck junction.  
 
:*The '''anterolateral approach''', with the ultrasound probe oriented axially and the femoral head and acetabular rim in view. This often shortens the distance from needle skin entry to joint compared to the longitudinal approach making it a useful approach in larger patients. The introduced needle remains lateral to the femoral neurovascular bundle, and the needle is advanced until its tip rests on the femoral head.  
 
:*The '''anterolateral approach''', with the ultrasound probe oriented axially and the femoral head and acetabular rim in view. This often shortens the distance from needle skin entry to joint compared to the longitudinal approach making it a useful approach in larger patients. The introduced needle remains lateral to the femoral neurovascular bundle, and the needle is advanced until its tip rests on the femoral head.  
−
[[File:Ultrasonography of hip joint injection by anterolateral approach.jpg|thumb|Anterolateral approach, here shown as a transverse image. The needle will rest on the femoral head (arrow). A, acetabulum; H, femoral head; N, femoral neck; LAT, lateral; MED, medial.<ref name="YeapRobinson2017"/>]]
+
<gallery mode=packed heights=200>
 +
File:Ultrasonography of hip joint injection by anterior longitudinal approach.jpg|Anterior longitudinal approach. The needle is introduced from an inferior and anterior approach, lateral to the femoral neurovascular bundle (arrow). A, acetabulum; H, femoral head; N, femoral neck; double arrow – anterior joint recess.<ref name="YeapRobinson2017"/>
 +
File:Ultrasonography of hip joint injection by anterolateral approach.jpg|Anterolateral approach, here shown as a transverse image. The needle will rest on the femoral head (arrow). A, acetabulum; H, femoral head; N, femoral neck; LAT, lateral; MED, medial.<ref name="YeapRobinson2017"/>
 +
</gallery>
 
*'''Draw''' a line parallel to the long axis of the transducer, on the skin adjacent to the end of the transducer is where the needle will be introduced.  
 
*'''Draw''' a line parallel to the long axis of the transducer, on the skin adjacent to the end of the transducer is where the needle will be introduced.  
 
*Perform '''sterile preparation''' of the entire injection field, including adjacent skin where the gel and probe are applied. Areas of superficial infection such as cellulitis or abscess should be avoided to prevent deeper spread.<ref name="YeapRobinson2017"/>
 
*Perform '''sterile preparation''' of the entire injection field, including adjacent skin where the gel and probe are applied. Areas of superficial infection such as cellulitis or abscess should be avoided to prevent deeper spread.<ref name="YeapRobinson2017"/>
 
*Using the previous mark, '''insert the needle''', directed toward the intended target. It can be done by a freehand technique,<ref name="YeapRobinson2017"/> but a needle guide may be used. Needles with a Birmingham Gauge of 22–24 are sufficed for most injections.<ref name="YeapRobinson2017"/>
 
*Using the previous mark, '''insert the needle''', directed toward the intended target. It can be done by a freehand technique,<ref name="YeapRobinson2017"/> but a needle guide may be used. Needles with a Birmingham Gauge of 22–24 are sufficed for most injections.<ref name="YeapRobinson2017"/>
  
−
==References==
+
==Report==
−
{{reflist}}
+
*Contents of injectate.
 +
*Absence of immediate complications, or a description thereof.
 +
 
 +
A more comprehensive report may also include:
 +
*Even the absence of hip effusion
 +
*Even the absence of joint capsule thickening or hyperemia
 +
*Patient informed about the pharmacodynamics of the injectate.
 +
 
 +
{{Reporting}}
 +
 
 +
{{Bottom}}

Latest revision as of 13:25, 22 March 2019

Author: Mikael Häggström [notes 1]

Contents

Planning

Choice of modality

Ultrasonography is generally superior for injections in the hip joint, because of portability, lack of ionizing radiation and real-time visualisation of soft tissues and neurovascular structures.[1]

Bleeding

The risk of clinically significant bleeding is minimal, so coagulation tests are not needed before the procedure. It can for example be performed during chronic warfarin therapy with therapeutic coagulation levels.[2]

Transducer choice

Preferably use a high-frequency (> 10 MHz) linear array transducer.[1] A lower-frequency curvilinear probes may occasionally be required in larger patients.[1]

Injectate

The total volume injected is usually 6–7ml.[1]

For pain relief in osteoarthritis, for example:

  • Local anesthetic
  • 300mg lidocaine (such as 3 ml of 10%)
  • 30mg mepivacaine (such as 3 ml of 1% Carbocaine)
  • 25mg bupivacaine (such as 5ml of Marcaine 0.5%)[3]
  • Glucocorticoid, for example:
  • 40mg triamcinolone (such as 1ml of 40 mg/ml)[3]

Patient information

In osteoarthritis patients, at least when not having had repeated injections, inform that the local anesthetic effect will wear off after about 4 to 6 hours, and it will take 2 to 7 days before the glucocorticoid will take effect, so that there may be increased pain in the meantime.[4]

Procedure

  • Perform a preliminary sonography, including color Doppler of the area to be punctured, to define the relationship of adjacent neurovascular structures.[1] Preferably, also evaluate the joint area for any joint effusion, or any thickening or hyperemia of the joint capsule.
  • Decide which approach to use. Two common anterior approaches are typically used both with the patient lying supine:
 
Anterior longitudinal approach. An arrow parallel to the long axis of the transducer is drawn on the skin adjacent to the end of transducer where the needle will be introduced.[1]
  • The anterior longitudinal approach: the probe is aligned along the long axis of the femoral neck. The needle is introduced from an anteroinferior approach and is passed into the anterior joint recess at the femoral head-neck junction.
  • The anterolateral approach, with the ultrasound probe oriented axially and the femoral head and acetabular rim in view. This often shortens the distance from needle skin entry to joint compared to the longitudinal approach making it a useful approach in larger patients. The introduced needle remains lateral to the femoral neurovascular bundle, and the needle is advanced until its tip rests on the femoral head.

  • Anterior longitudinal approach. The needle is introduced from an inferior and anterior approach, lateral to the femoral neurovascular bundle (arrow). A, acetabulum; H, femoral head; N, femoral neck; double arrow – anterior joint recess.[1]

  • Anterolateral approach, here shown as a transverse image. The needle will rest on the femoral head (arrow). A, acetabulum; H, femoral head; N, femoral neck; LAT, lateral; MED, medial.[1]

  • Draw a line parallel to the long axis of the transducer, on the skin adjacent to the end of the transducer is where the needle will be introduced.
  • Perform sterile preparation of the entire injection field, including adjacent skin where the gel and probe are applied. Areas of superficial infection such as cellulitis or abscess should be avoided to prevent deeper spread.[1]
  • Using the previous mark, insert the needle, directed toward the intended target. It can be done by a freehand technique,[1] but a needle guide may be used. Needles with a Birmingham Gauge of 22–24 are sufficed for most injections.[1]

Report

  • Contents of injectate.
  • Absence of immediate complications, or a description thereof.

A more comprehensive report may also include:

  • Even the absence of hip effusion
  • Even the absence of joint capsule thickening or hyperemia
  • Patient informed about the pharmacodynamics of the injectate.
See also: General notes on reporting

Notes

  1. ↑ For a full list of contributors, see article history. Creators of images are attributed at the image description pages, seen by clicking on the images. See Radlines:Authorship for details.

References

  1. ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 Initially largely copied from: Yeap, Phey Ming; Robinson, Philip (2017). "Ultrasound Diagnostic and Therapeutic Injections of the Hip and Groin ". Journal of the Belgian Society of Radiology 101 (S2). doi:10.5334/jbr-btr.1371. ISSN 2514-8281. 
    Creative Commons Attribution 4.0 International License (CC-BY 4.0)
  2. ↑ Ahmed, Imdad; Gertner, Elie (2012). "Safety of Arthrocentesis and Joint Injection in Patients Receiving Anticoagulation at Therapeutic Levels ". The American Journal of Medicine 125 (3): 265–269. doi:10.1016/j.amjmed.2011.08.022. ISSN 00029343. 
  3. ↑ 3.0 3.1 Anderson, Erik; Herring, Andrew; Bailey, Caitlin; Mantuani, Daniel; Nagdev, Arun (2013). "Ultrasound-guided Intraarticular Hip Injection for Osteoarthritis Pain in the Emergency Department ". Western Journal of Emergency Medicine 14 (5): 505–508. doi:10.5811/westjem.2013.2.13966. ISSN 1936900X. 
  4. ↑ Benjamin Ma. Hip joint injection. MedlinePlus (United States National Library of Medicine). Retrieved on 2019-03-22. Review Date 11/27/2016
Retrieved from "https://radlines.org/index.php?title=Ultrasound-guided_hip_joint_injection&oldid=3193"